Status:
COMPLETED
Reduction of Arm Volume and Improvement in Lymphedema Via Surgery
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Lymphedema
Lymphedema Arm
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
This clinical trial aims to evaluate the effectiveness of lymphatic microsurgical treatments in reducing limb volume in female patients with breast cancer-related lymphedema (BCRL). The study focuses...
Detailed Description
This clinical trial aims to explore the effectiveness of surgical interventions for breast cancer-related lymphedema (BCRL), a chronic and often debilitating condition caused by lymphatic system damag...
Eligibility Criteria
Inclusion
- at least one of the following persistent complaints of one of the upper extremities: heaviness, pain, recurrent infections
Exclusion
- negative volume difference between affected and normal limb, bilateral mastectomy, bilateral axillary lymph node dissection (ALND), ongoing radio- and chemotherapy, ISL stage III, and receiving other simultaneous debulking procedures during lymphedema surgery.
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
179 Patients enrolled
Trial Details
Trial ID
NCT06606145
Start Date
January 1 2011
End Date
December 1 2022
Last Update
September 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitair Ziekenhuis Brussel
Jette, Brussel Capital, Belgium, 1090